Indications for use
The primary indication for prescribing nifurtimox is New World trypanosomiasis. This disease is caused by the unicellular parasite Trypanosoma cruzi and requires specific etiotropic therapy to prevent severe organ damage.
Biochemical mechanism of action
The pharmacological effect of the drug relies on the development of oxidative stress inside the pathogen cell:
- Upon entering the parasite's body, the substance is transformed into nitroaryl radicals.
- The resulting radicals react to release peroxide anions.
- As a result of further interaction with water, cytotoxic hydrogen peroxide ($H_2O_2$) is synthesized, which is lethal to the pathogen.
Basis of therapy selectivity
The selectivity of the drug's action is explained by differences in antioxidant systems:
- Trypanosoma cruzi completely lacks catalase and enzymes capable of breaking down peroxides, making the parasite extremely vulnerable to nitroaromatic compounds.
- Mammalian organisms are reliably protected by their own antioxidant defense enzymes, which include catalase, glutathione peroxidase, and superoxide dismutase.
Adverse reactions
The use of the agent is accompanied by a number of undesirable manifestations from the nervous system and gastrointestinal tract. Patients may experience anorexia and vomiting, as well as neurological disorders including sleep disturbances, memory impairment, and seizures.
Briefly: answers to topical questions
What drugs are used for the etiotropic treatment of Chagas disease?
Nifurtimox is used for the etiotropic treatment of Chagas disease (American trypanosomiasis).
- Nifurtimox (Nifurtimox) — indicated for New World trypanosomiasis, caused by Trypanosoma cruzi.
The mechanism of action of the drug is associated with the development of oxidative stress. Within the protozoan's body, it is reduced to nitroaryl radicals, which are then oxidized to form peroxide anions. The subsequent reaction with water leads to the formation of cytotoxic hydrogen peroxide. The parasite's high sensitivity to the drug is due to the absence of catalase and other peroxide-scavenging enzymes.
Nifurtimox — A "nitro bridge" to peroxide: a parasite lacking catalase burns from oxidative stress.
Class and exam questions
Which pathogen is sensitive to nifurtimox?
The drug is effective against the causative agent of New World trypanosomiasis — Trypanosoma cruzi.
Why is nifurtimox selectively toxic only to the parasite?
The parasite lacks protective enzymes (e.g., catalase), whereas human cells are protected by catalase, glutathione peroxidase, and superoxide dismutase.
What adverse effects are characteristic of this agent?
Anorexia, vomiting, memory impairment, sleep disturbances, and seizures are possible.
What else to study on this topic
- The role of superoxide dismutase and catalase in mammalian cells
- Detailed stages of the reduction of nitroaromatic compounds
- Clinical presentation of Chagas disease and its phases
- Comparative profile of other antitrypanosomal agents
- Ways to manage neurological side effects of the drug
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Drugs for the treatment of Chagas disease" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Drugs for protozoan infections" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.